Literature DB >> 12122955

The impact of influenza in children.

Flor M Munoz1.   

Abstract

The highest infection rates with influenza virus occur in young children because of their lack of prior immunity and prior exposure to the virus. Most children with influenza virus infection are healthy otherwise. Previously healthy children who have influenza in their first year of life have a substantial risk for developing serious disease. An underlying chronic medical condition further increases this risk. Infants, young children, and children with underlying conditions have the highest rates of outpatient medical visits and hospitalizations for acute respiratory disease during influenza epidemics. Secondary bacterial infections, antibiotic use, and other complications of influenza are consequences of influenza virus infection in children of all ages. Annual immunization with influenza vaccine is recommended for any child older than 6 months of age in whom prevention of disease is desirable, and particularly in those with underlying medical conditions. The consequences of infection in infants younger than 6 months of age can be modified by maternal immunization currently recommended for women in the second or third trimester of pregnancy during the influenza season. Family members, including siblings, and all other close contacts should receive influenza vaccine to reduce the possibility of transmission to children at risk. Immunization of all children has a positive impact on the occurrence of influenza infection and its complications, both in those at greater risk and in the entire population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12122955     DOI: 10.1053/spid.2002.122992

Source DB:  PubMed          Journal:  Semin Pediatr Infect Dis        ISSN: 1045-1870


  19 in total

1.  Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the Department of Health.

Authors: 
Journal:  Thorax       Date:  2007-01       Impact factor: 9.139

2.  Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.

Authors:  Luis Salleras; Encarna Navas; Nuria Torner; Andreu A Prat; Patricio Garrido; Núria Soldevila; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

3.  [Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra®].

Authors:  Sara Boccalini; Elena Pariani; Giovanna Elisa Calabrò; Chiara DE Waure; Donatella Panatto; Daniela Amicizia; Piero Luigi Lai; Caterina Rizzo; Emanuele Amodio; Francesco Vitale; Alessandra Casuccio; Maria Luisa DI Pietro; Cristina Galli; Laura Bubba; Laura Pellegrinelli; Leonardo Villani; Floriana D'Ambrosio; Marta Caminiti; Elisa Lorenzini; Paola Fioretti; Rosanna Tindara Micale; Davide Frumento; Elisa Cantova; Flavio Parente; Giacomo Trento; Sara Sottile; Andrea Pugliese; Massimiliano Alberto Biamonte; Duccio Giorgetti; Marco Menicacci; Antonio D'Anna; Claudia Ammoscato; Emanuele LA Gatta; Angela Bechini; Paolo Bonanni
Journal:  J Prev Med Hyg       Date:  2021-09-10

4.  Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005.

Authors:  Patrick H Peters; Anne Moscona; Kathy L Schulman; Charles E Barr
Journal:  Medscape J Med       Date:  2008-06-04

5.  Novel virus influenza A (H1N1sw) in South-Eastern France, April-August 2009.

Authors:  Antoine Nougairède; Laetitia Ninove; Christine Zandotti; Nicolas Salez; Karine Mantey; Noémie Resseguier; Céline Gazin; Didier Raoult; Rémi N Charrel; Xavier de Lamballerie
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

6.  Relative impact of influenza and respiratory syncytial virus in young children.

Authors:  Florence T Bourgeois; Clarissa Valim; Alexander J McAdam; Kenneth D Mandl
Journal:  Pediatrics       Date:  2009-11-23       Impact factor: 7.124

7.  Molecular Epidemiology and Vaccine Compatibility Analysis of Seasonal Influenza Viruses in Wuhan, 2016-2019.

Authors:  Liang-Jun Chen; Jing-Jing Guo; Wei-Wei Guo; E-Xiang Shen; Xin Wang; Kai-Ji Li; Jie Yan; Mang Shi; Yi-Rong Li; Wei Hou
Journal:  Virol Sin       Date:  2020-05-11       Impact factor: 4.327

8.  Quality of life for parents of children with influenza-like illness: development and validation of Care-ILI-QoL.

Authors:  Maria Yui Kwan Chow; Angela Morrow; Leon Heron; Jiehui Kevin Yin; Robert Booy; Julie Leask
Journal:  Qual Life Res       Date:  2013-10-01       Impact factor: 4.147

9.  Persistent Airway Hyperresponsiveness Following Recovery from Infection with Pneumonia Virus of Mice.

Authors:  Ajinkya R Limkar; Caroline M Percopo; Jamie L Redes; Kirk M Druey; Helene F Rosenberg
Journal:  Viruses       Date:  2021-04-22       Impact factor: 5.048

10.  Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons.

Authors:  Seoung Geun Kim; Yoon Ha Hwang; Yung Hae Shin; Sung Won Kim; Woo Sik Jung; Sung Mi Kim; Jae Min Oh; Na Young Lee; Mun Ju Kim; Kyung Soon Cho; Yeon Gyeong Park; Sang Kee Min; Chang Kyu Lee; Jun Sub Kim; Chun Kang; Joo Yeon Lee; Man Kyu Huh; Chang Hoon Kim
Journal:  Korean J Pediatr       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.